Safety Alert for Birmingham Hip Modular Heads

According to Department of Health, this safety alert involved a device in Hong Kong that was produced by Smith and Nephew.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Date
    2012-09-25
  • Event Date Posted
    2012-09-25
  • Event Country
  • Event Source
    DH
  • Event Source URL
  • Notes / Alerts
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Extra notes in the data
    Medical Device Safety Alert
  • Reason
    Medical device safety alert: smith and nephew birmingham hip modular heads medical device manufacturer, smith and nephew, has issued a field safety notice concerning birmingham hip modular heads. according to the manufacturer, the average revision rate for the birmingham hip modular head with all stems is currently 1.29 revisions per 100 observed component years in the national joint registry of england and wales and 1.12 revisions per 100 observed component years in the australian orthopaedic association’s national joint replacement registry. these rates exceed the 1% benchmark revision rate established by the uk’s national institute for health and clinical excellence. however, if combined with the uncemented synergy stem, the revision rate is 1.07 revisions per 100 observed years which is acceptable and comparable to other clinically successful hip implants on the market. owing to the above reason, the manufacturer has updated the device’s instructions for use (ifu) (lit. no. 81036947 rev d 03/10 for the application of the birmingham hip modular head). a new stand-alone ifu for the affected product is issued, which includes updates on the contraindications, indications and additional warnings. the sections “information on hydroxyapatite implants” and “information on porous coated implants” that are specific to cups have been removed from the ifu. furthermore, the manufacturer advised users to use the affected product only in accordance with the revised indications for use in the revised ifu. according to the local supplier, the affected devices were distributed in hong kong. if you are in possession of the products, please contact your supplier for necessary actions. posted on 25 september 2012.

Device

  • Model / Serial
  • Product Description
    Medical Device Safety Alert: Smith and Nephew Birmingham Hip Modular Heads
  • Manufacturer

Manufacturer